CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma (vol 14, pg 4673, 2022)Dan Zi,Qing Li,Cheng-Xiong Xu,Zhi-Wei Zhou,Guan-Bin Song,Cheng-Bin Hu,Fang Wen,Han-Lin Yang,Lei Nie,Xing Zhao,Jun Tan,Shu-Feng Zhou,Zhi-Xu HeAGING-US(2023)引用 2|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要